Suggested indications for early allogeneic stem cell transplantation for a newly diagnosed patient with chronic myeloid leukemia (CML).
| • Intermediate or high risk (European score) |
| HLA-identical sibling donor |
| Age less than 45 years |
| • Low risk (European score) |
| HLA-identical sibling donor |
| Age less than 35 years |
| • Intermediate or high risk (European score) |
| Molecularly matched unrelated (or family) donor |
| Age less than 35 years |
| • Low risk (European score) |
| Molecularly matched unrelated (or family) donor |
| Age less than 25 years |
| • Intermediate or high risk (European score) |
| HLA-identical sibling donor |
| Age less than 45 years |
| • Low risk (European score) |
| HLA-identical sibling donor |
| Age less than 35 years |
| • Intermediate or high risk (European score) |
| Molecularly matched unrelated (or family) donor |
| Age less than 35 years |
| • Low risk (European score) |
| Molecularly matched unrelated (or family) donor |
| Age less than 25 years |